Cargando…

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

BACKGROUND: The hypoxia marker pimonidazole is a candidate biomarker of cancer aggressiveness. We investigated the transcriptional programme associated with pimonidazole staining in prostate cancer. METHODS: Index tumour biopsies were taken by image guidance from an investigation cohort of 52 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ragnum, H B, Vlatkovic, L, Lie, A K, Axcrona, K, Julin, C H, Frikstad, K M, Hole, K H, Seierstad, T, Lyng, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453458/ https://www.ncbi.nlm.nih.gov/pubmed/25461803 http://dx.doi.org/10.1038/bjc.2014.604

Ejemplares similares

Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
por: Ameri, K, et al.
Publicado: (2010)

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022)

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
por: Hamano, R, et al.
Publicado: (2012)

Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)
por: Hong, H, et al.
Publicado: (2011)

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
por: Couvelard, A, et al.
Publicado: (2005)

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
por: Jonsson, Marte, et al.
Publicado: (2016)

Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
por: Miyamoto, K, et al.
Publicado: (2016)

Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis
por: Cao, R, et al.
Publicado: (2014)

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
por: Nam, S Y, et al.
Publicado: (2011)

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
por: Bullock, M D, et al.
Publicado: (2013)

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
por: Molleví, D G, et al.
Publicado: (2008)

Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia
por: Olive, P L, et al.
Publicado: (2000)

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
por: Nalwoga, H, et al.
Publicado: (2010)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia
por: Koukourakis, M I, et al.
Publicado: (2010)

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
por: Hamana, K, et al.
Publicado: (2005)

Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
por: Hole, Knut Håkon, et al.
Publicado: (2012)

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis
por: Walsh, N, et al.
Publicado: (2010)

Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
por: Barathova, M, et al.
Publicado: (2008)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib
por: Kimura, H, et al.
Publicado: (2006)

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
por: Hirotsu, M, et al.
Publicado: (2009)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
por: Yoshino, H, et al.
Publicado: (2011)

Expression of laminin 5-γ2 chain in cutaneous squamous cell carcinoma and its role in tumour invasion
por: Hamasaki, H, et al.
Publicado: (2011)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Tumour-suppressive function of SIRT4 in human colorectal cancer
por: Miyo, M, et al.
Publicado: (2015)

Direct T cell–tumour interaction triggers T(H)1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme
por: Jin, P, et al.
Publicado: (2014)

Tumour heterogeneity poses a significant challenge to cancer biomarker research
por: Cyll, Karolina, et al.
Publicado: (2017)

Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer
por: Kaneda, H, et al.
Publicado: (2011)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
por: Ino, K, et al.
Publicado: (2006)

Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation
por: Masur, K, et al.
Publicado: (2011)

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
por: Mizukami, Y, et al.
Publicado: (2008)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells
por: Chien, W, et al.
Publicado: (2013)

Clinical significance of disseminated tumour cells in non-small cell lung cancer
por: Rud, A K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i7mtadvjrbqnf022hromtpvr40